Roivant Sciences (ROIV) EBITDA Margin (2021 - 2026)
Roivant Sciences' EBITDA Margin came in at -25339.32% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 12259.87 percentage points from -13079.45% a year earlier and down 41842.42 percentage points from the prior quarter.
Roivant Sciences (ROIV) EBITDA Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Roivant Sciences reported EBITDA Margin of -7876.91%, down 2816.46 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at -6195.16%, down 2790.27 percentage points from FY2025.
- EBITDA Margin carries a four-year change of -3761.07 percentage points (FY2022 to FY2026).
- Going back by fiscal year, EBITDA Margin was -3404.89% in FY2025 (-17219.18 pp), 13814.29% in FY2024 (+16630.36 pp), -2816.07% in FY2023 (-381.98 pp) and -2434.09% in FY2022.
- The fiscal Q1 2027 figure represents the lowest quarterly EBITDA Margin in data going back to fiscal Q3 2022.
- Year-over-year, EBITDA Margin increased in 1 of the last eight quarters, with an average year-over-year change of -8627.69 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in fiscal Q3 2024 (a gain of 35170.16 percentage points), and the weakest in fiscal Q3 2025 (a drop of 35993.37 percentage points).
- Business Quant data shows ROIV's EBITDA Margin at 16503.10% (Q4 2026), -16931.57% (Q3 2026) and -19434.25% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | -25,339.32% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25,339.32% |
| Mar 31, 2026 | 16,503.10% |
| Dec 31, 2025 | -16,931.57% |
| Sep 30, 2025 | -19,434.25% |
| Jun 30, 2025 | -13,079.45% |
| Mar 31, 2025 | -3,745.57% |
| Dec 31, 2024 | -3,010.20% |
| Sep 30, 2024 | -7,527.84% |
| Jun 30, 2024 | -1,218.42% |
| Mar 31, 2024 | -2,235.13% |
| Dec 31, 2023 | 32,983.16% |
| Sep 30, 2023 | -5,710.09% |
| Jun 30, 2023 | -1,251.27% |
| Dec 31, 2022 | -2,186.99% |
| Sep 30, 2022 | -2,199.72% |
| Jun 30, 2022 | -6,474.44% |
| Mar 31, 2022 | -2,874.30% |
| Dec 31, 2021 | -1,005.11% |
Roivant Sciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();